H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodFiling Growth
16 → 16 filings, FY2021 to FY2025 (latest year appears partial)Top Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| AstraZeneca Pharmacetuicals LP | 5 | $145,000 | $134,100 - $158,400 | 100.0% |
| Novo Nordisk Inc. | 3 | $199,326 | $185,000 - $202,020 | 100.0% |
| Q32 Bio Inc | 3 | $160,000 | $160,000 - $182,000 | 66.7% |
| BEIGENE USA, INC | 3 | $175,000 | $170,000 - $192,000 | 100.0% |
| HIKMA PHARMACEUTICALS USA INC. | 3 | $135,000 | $134,285 - $155,000 | 66.7% |
| SAGE THERAPEUTICS | 3 | $178,500 | $138,098 - $180,294 | 100.0% |
| STAAR SURGICAL COMPANY | 3 | $180,000 | $150,000 - $209,050 | 100.0% |
| Celldex Therapeutics, Inc. | 3 | $162,930 | $156,430 - $195,000 | 100.0% |
| Teva Pharmaceuticals USA, Inc. | 3 | $187,866 | $148,075 - $187,866 | 66.7% |
| ClinChoice Inc. dba FMD KL Inc. | 3 | $113,589 | $113,589 - $113,589 | 33.3% |
| Alcon Research, LLC | 3 | $182,000 | $155,480 - $182,000 | 66.7% |
| SBM Life Sciences Corp | 2 | $110,575 | $106,454 - $114,695 | 100.0% |
| PAI Holdings LLC | 2 | $132,735 | $117,000 - $148,470 | 100.0% |
| Allergan Sales, LLC | 2 | $142,000 | $124,000 - $160,000 | 100.0% |
| BECTON DICKINSON AND COMPANY | 2 | $175,000 | $175,000 - $175,000 | 50.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 85 | $160,000 | $92,477 - $215,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 6 | $165,000 |
| Gaithersburg | MD | 5 | $145,000 |
| Union | SC | 3 | $128,731 |
| Parsippany | NJ | 3 | $187,866 |
| New Haven | CT | 3 | $162,930 |
| IRVINE | CA | 3 | $138,029 |
| Odessa | FL | 3 | $117,000 |
| San Jose | CA | 3 | $182,000 |
| Fort Washington | PA | 3 | $113,589 |
| Haddon Township | NJ | 2 | $162,500 |
Across the 244,862 petitions we hold for the H-1B cap lottery as a whole, the I-129 filing records the beneficiary's actual pay alongside their country of birth, education and gender. A raw pay gap between two groups is mostly a statement about which jobs they hold — so each gap below is shown twice: as it looks raw, and again measured within the same job title. The second number is the one to read.
Gender is here as the control. Our decomposition of the H-1B gender pay gap found that gap is sorting almost entirely — it survives the correction at under a percent. Country of birth and education do not behave that way: part of each gap is job mix, and a real difference is still standing after the correction.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| India | 164,659 | $90,397 | -$2,288 | -$2,411 | — |
| China | 35,095 | $110,000 | +$17,315 | +$8,896 | 48.6% |
| Philippines | 1,863 | $64,000 | -$28,685 | -$594 | 97.9% |
60 other values (39,441 petitions) are not shown, because too few of their petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Master's degree | 102,816 | $91,104 | -$896 | -$262 | — |
| Bachelor's degree | 88,784 | $90,000 | -$2,000 | -$1,219 | 39.0% |
| Doctorate degree | 11,783 | $128,400 | +$36,400 | +$17,739 | 51.3% |
| Professional degree | 2,272 | $150,000 | +$58,000 | +$24,154 | 58.4% |
One other value (103 petitions) is not shown, because too few of its petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Men | 164,128 | $93,891 | +$1,206 | -$361 | — |
| Women | 80,734 | $90,000 | -$2,685 | +$469 | — |
How to read this. The within-occupation figure compares people holding the same job title, weighted by how many petitions sit in each title. Titles encode seniority, so equal pay within a title does not rule out differences in reaching that title — the same limitation that applies to any controlled pay-gap number. Figures are base pay only: the I-129 reports prospective base compensation, with no equity or bonus, so this is not total compensation. Coverage is FY2021–FY2024 cap-subject H-1B lottery petitions that carry both a pay figure and a job title — a one-time FOIA snapshot, not a live feed. Aggregates only, with small counts suppressed. Source: I-129 petition data sourced from USCIS, obtained by Bloomberg.
These roles are variations of Associate Director, Regulatory Affairs with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Associate Director, Regulatory Affairs | 126 | $154,357 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 16 | $147,618 | 75.0% |
| 2022 | 14 | $167,500 | 85.7% |
| 2023 | 17 | $160,000 | 82.4% |
| 2024 | 11 | $169,309 | 100.0% |
| 2025 | 16 | $170,022 | 87.5% |
| 2026 | 11 | $193,800 | 81.8% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| AstraZeneca Pharmacetuicals LP | 5 | $145,000 | 100.0% |
| Novo Nordisk Inc. | 3 | $199,326 | 100.0% |
| Q32 Bio Inc | 3 | $160,000 | 66.7% |
| BEIGENE USA, INC | 3 | $175,000 | 100.0% |
| HIKMA PHARMACEUTICALS USA INC. | 3 | $135,000 | 66.7% |